Please provide your email address to receive an email when new articles are posted on . Retia Medical announced that a cardiac output monitoring device for patients who are at high surgical risk or ...
The FDA granted a 510(k) clearance to Retia Medical’s hemodynamic monitoring device for measuring a patient’s cardiac output in intensive care units or the operating room. The Valhalla, New York-based ...
Introduction: Bioreactance, the analysis of intrabeat variations in response to high frequency transthoracic current, is a new method for noninvasive cardiac output measurement (NICOM). The objective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback